サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1423950

解毒剤市場、シェア、規模、動向、産業分析レポート：タイプ別、投与経路別、流通チャネル別、最終用途別、地域別、セグメント別予測、2024年～2032年

Antidote Market Share, Size, Trends, Industry Analysis Report, By Type (Chemical Antidote, Physical Antidote, Pharmacological Antidote), By Route of Administration, By Distribution Channel, By End-use, By Region, And Segment Forecasts, 2024- 2032

出版日
ページ情報
英文 116 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.90円
解毒剤市場、シェア、規模、動向、産業分析レポート：タイプ別、投与経路別、流通チャネル別、最終用途別、地域別、セグメント別予測、2024年～2032年
出版日: 2024年01月24日
発行: Polaris Market Research
ページ情報: 英文 116 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Research社の最新調査によると、解毒剤の世界市場規模は2032年までに40億5,236万米ドルに達する見込みです。このレポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

同市場は、ヘビ咬傷の流行と関連する悪影響によって主に推進されています。例えば、2023年にPLOSに掲載された調査論文では、インドにおけるヘビ咬傷に起因する約58,000人の死亡が報告されています。さらに、薬物の過剰摂取の増加が市場の主要な促進要因となっています。米国保健社会福祉省によると、米国では2021年に約106,699人の薬物過剰摂取による死亡が記録されています。解毒剤は特定の薬物を中和する働きがあります。例えば、ナロキソンはオピオイド過剰摂取時の呼吸抑制を回復させるために一般的に使用されています。解毒剤のこうした機能は市場の成長に寄与しています。

さらに、職業中毒の有病率の上昇が、解毒剤の需要の高まりに重要な役割を果たしています。オピオイド過剰摂取、青酸中毒、CO中毒、鉛中毒、有機リン酸中毒などの発生率の増加により、解毒剤の用途は拡大しています。例えば、2020年12月のNCBIによる調査論文によると、世界では意図しない農薬中毒が約3億8,500万件発生し、1万1,000人が死亡しています。その結果、市場は予測期間中に急成長を遂げると予想されます。

さらに、毒素の識別に関する一般市民の教育を目的とした一連の意識向上イニシアティブは、解毒剤と薬剤の知識を強化する政府の取り組みと相まって、市場全体の成長を促進すると予想されます。その反面、現在進行中の研究開発は、毒物中毒や有毒物質への暴露を管理する上で、利用可能性、有効性、安全性を向上させることに重点を置いており、近いうちに市場に有利な機会をもたらすと思われます。

しかし、製造上の制約や規制上のハードルにより、解毒剤の入手可能性が限られていることが、救命解毒剤へのアクセスを妨げる可能性があります。ある種の解毒剤に関連する高コストは、経済的な障壁となる可能性があります。さらに、保管条件、保存期間、知識と訓練の必要性が、解毒剤の応用を制約するかもしれないです。

解毒剤市場レポートハイライト

化学的な解毒剤が最大のシェアを占めています。

入院患者数の増加、打撃施設、訓練を受けた医療専門家により、病院が市場を独占

オピオイド危機、中毒事例の増加、研究開発に携わる主要企業の存在により、北米が最大シェアを占めました。

主な市場企業は、ファイザー、ヒクマ・ファーマシューティカルズ、マイラン、フレゼニウス、ザイダス・ライフサイエンシズ、エンド・インターナショナル、バクスター、エマージェント・バイオソリューションズなどです。

目次

イントロダクション

  • レポートの説明
    • 研究の目的
    • 市場範囲
    • 仮定
  • 利害関係者

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界の解毒剤市場に関する洞察

  • 解毒剤市場 - 流通チャネルのスナップショット
  • 解毒剤市場力学
    • 促進要因と機会
      • 中毒発生率の増加
      • 増加する薬物乱用
    • 抑制要因と課題
      • 高いコスト
  • PESTEL分析
  • 解毒剤市場の流通チャネルの動向
  • バリューチェーン分析
  • COVID-19感染症の影響分析

第5章 世界の解毒剤市場：投与経路別

  • 主な調査結果
  • イントロダクション
  • 経口
  • 局所
  • 注射
  • その他

第6章 世界の解毒剤市場：タイプ別

  • 主な調査結果
  • イントロダクション
  • 化学的解毒剤
  • 物理的解毒剤
  • 薬理学的解毒剤

第7章 世界の解毒剤市場：流通チャネル別

  • 主な調査結果
  • イントロダクション
  • 病院薬局
  • 小売薬局
  • オンライン薬局

第8章 世界の解毒剤市場：地域別

  • 主な調査結果
  • イントロダクション
    • 解毒剤市場評価、地域別、2019年～2032年
  • 解毒剤市場 - 北米
    • 北米：解毒剤市場、投与経路別、2019年～2032年
    • 北米：解毒剤市場、流通チャネル別、2019年～2032年
    • 北米：解毒剤市場、タイプ別、2019年～2032年
    • 解毒剤市場 - 米国
    • 解毒剤市場 - カナダ
  • 解毒剤市場 - 欧州
    • 欧州：解毒剤市場、投与経路別、2019年～2032年
    • 欧州：解毒剤市場、流通チャネル別、2019年～2032年
    • 欧州：解毒剤市場、タイプ別、2019年～2032年
    • 解毒剤市場 - 英国
    • 解毒剤市場 - フランス
    • 解毒剤市場 - ドイツ
    • 解毒剤市場 - イタリア
    • 解毒剤市場 - スペイン
    • 解毒剤市場 - オランダ
    • 解毒剤市場 - ロシア
  • 解毒剤市場 - アジア太平洋
    • アジア太平洋：解毒剤市場、投与経路別、2019年～2032年
    • アジア太平洋：解毒剤市場、流通チャネル別、2019年～2032年
    • アジア太平洋：解毒剤市場、タイプ別、2019年～2032年
    • 解毒剤市場 - 中国
    • 解毒剤市場 - インド
    • 解毒剤市場 - マレーシア
    • 解毒剤市場 - 日本
    • 解毒剤市場 - インドネシア
    • 解毒剤市場 - 韓国
  • 解毒剤市場 - 中東・アフリカ
    • 中東・アフリカ：解毒剤市場、投与経路別、2019年～2032年
    • 中東・アフリカ：解毒剤市場、流通チャネル別、2019年～2032年
    • 中東・アフリカ：解毒剤市場、タイプ別、2019年～2032年
    • 解毒剤市場 - サウジアラビア
    • 解毒剤市場 - アラブ首長国連邦
    • 解毒剤市場 - イスラエル
    • 解毒剤市場 - 南アフリカ
  • 解毒剤市場 - ラテンアメリカ
    • ラテンアメリカ：解毒剤市場、投与経路別、2019年～2032年
    • ラテンアメリカ：解毒剤市場、流通チャネル別、2019年～2032年
    • ラテンアメリカ：解毒剤市場、タイプ別、2019年～2032年
    • 解毒剤市場 - メキシコ
    • 解毒剤市場 - ブラジル
    • 解毒剤市場 - アルゼンチン

第9章 競合情勢

  • 拡張と買収の分析
    • 拡大
    • 買収
  • 提携/協業/合意/公開

第10章 企業プロファイル

  • Pfizer Inc.
  • Hikma Pharmaceuticals PLC
  • Dr. Reddy's Laboratories Ltd
  • Mylan N.V.
  • Fresenius Kabi AG
  • Zydus Lifesciences Ltd.
  • Endo International plc
  • Novartis AG
  • Baxter International, Inc.
  • Emergent BioSolutions Inc
図表

List of Tables

  • Table 1 Global Antidote Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 2 Global Antidote Market, by Type, 2019-2032 (USD Million)
  • Table 3 Global Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 4 Antidote Market Assessment, By Geography, 2019-2032 (USD Million)
  • Table 5 North America: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 6 North America: Antidote Market, by Type, 2019-2032 (USD Million)
  • Table 7 North America: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 8 U.S.: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 9 U.S.: Antidote Market, by Type, 2019-2032 (USD Million)
  • Table 10 U.S.: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 11 Canada: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 12 Canada: Antidote Market, by Type, 2019-2032 (USD Million)
  • Table 13 Canada: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 14 Europe: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 15 Europe: Antidote Market, by Type, 2019-2032 (USD Million)
  • Table 16 Europe: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 17 UK: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 18 UK: Antidote Market, by Type, 2019-2032 (USD Million)
  • Table 19 UK: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 20 France: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 21 France: Antidote Market, by Type, 2019-2032 (USD Million)
  • Table 22 France: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 23 Germany: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 24 Germany: Antidote Market, by Type, 2019-2032 (USD Million)
  • Table 25 Germany: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 26 Italy: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 27 Italy: Antidote Market, by Type, 2019-2032 (USD Million)
  • Table 28 Italy: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 29 Spain: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 30 Spain: Antidote Market, by Type, 2019-2032 (USD Million)
  • Table 31 Spain: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 32 Netherlands: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 33 Netherlands: Antidote Market, by Type, 2019-2032 (USD Million)
  • Table 34 Netherlands: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 35 Russia: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 36 Russia: Antidote Market, by Type, 2019-2032 (USD Million)
  • Table 37 Russia: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 38 Asia Pacific: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 39 Asia Pacific: Antidote Market, by Type, 2019-2032 (USD Million)
  • Table 40 Asia Pacific: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 41 China: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 42 China: Antidote Market, by Type, 2019-2032 (USD Million)
  • Table 43 China: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 44 India: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 45 India: Antidote Market, by Type, 2019-2032 (USD Million)
  • Table 46 India: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 47 Malaysia: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 48 Malaysia: Antidote Market, by Type, 2019-2032 (USD Million)
  • Table 49 Malaysia: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 50 Japan: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 51 Japan: Antidote Market, by Type, 2019-2032 (USD Million)
  • Table 52 Japan: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 53 Indonesia: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 54 Indonesia: Antidote Market, by Type, 2019-2032 (USD Million)
  • Table 55 Indonesia: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 56 South Korea: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 57 South Korea: Antidote Market, by Type, 2019-2032 (USD Million)
  • Table 58 South Korea: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 59 Middle East & Africa: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 60 Middle East & Africa: Antidote Market, by Type, 2019-2032 (USD Million)
  • Table 61 Middle East & Africa: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 62 Saudi Arabia: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 63 Saudi Arabia: Antidote Market, by Type, 2019-2032 (USD Million)
  • Table 64 Saudi Arabia: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 65 UAE: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 66 UAE: Antidote Market, by Type, 2019-2032 (USD Million)
  • Table 67 UAE: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 68 Israel: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 69 Israel: Antidote Market, by Type, 2019-2032 (USD Million)
  • Table 70 Israel: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 71 South Africa: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 72 South Africa: Antidote Market, by Type, 2019-2032 (USD Million)
  • Table 73 South Africa: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 74 Latin America: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 75 Latin America: Antidote Market, by Type, 2019-2032 (USD Million)
  • Table 76 Latin America: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 77 Mexico: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 78 Mexico: Antidote Market, by Type, 2019-2032 (USD Million)
  • Table 79 Mexico: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 80 Brazil: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 81 Brazil: Antidote Market, by Type, 2019-2032 (USD Million)
  • Table 82 Brazil: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 83 Argentina: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 84 Argentina: Antidote Market, by Type, 2019-2032 (USD Million)
  • Table 85 Argentina: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)

List of Figures

  • Figure 1. Global Antidote Market, 2019-2032 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Type
  • Figure 7. Global Antidote Market, by Type, 2022 & 2032 (USD Million)
  • Figure 8. Market by Route of Administration
  • Figure 9. Global Antidote Market, by Route of Administration, 2022 & 2032 (USD Million)
  • Figure 10. Market by Distribution Channel
  • Figure 11. Global Antidote Market, by Distribution Channel, 2022 & 2032 (USD Million)
  • Figure 12. Antidote Market Assessment, By Geography, 2019-2032 (USD Million)
  • Figure 13. Strategic Analysis - Antidote Market
目次
Product Code: PM4182

The global antidote market size is expected to reach USD 4,052.36 Million by 2032, according to a new study by Polaris Market Research. The report "Antidote Market Share, Size, Trends, Industry Analysis Report, By Type (Chemical Antidote, Physical Antidote, Pharmacological Antidote), By Route of Administration, By Distribution Channel, By End-use, By Region, And Segment Forecasts, 2024- 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The market is predominantly propelled by the prevalence of snakebites and the associated adverse effects. For instance, a research article published in PLOS in 2023 reported approximately 58,000 deaths in India attributed to snake bites. Additionally, the increase in the number of drug overdoses is a key driver for the market. According to the U.S. Department of Health & Human Services, around 106,699 drug overdose deaths were recorded in the U.S. in 2021. Antidotes work to neutralize specific drugs. For instance, Naloxone is commonly used to reverse respiratory depression in opioid overdoses. These capabilities of antidotes contribute to the growth of the market.

Moreover, the escalating prevalence of occupational poisoning is playing a significant role in the heightened demand for antidotes. The applications of antidotes are expanding due to the increasing incidence of conditions such as opioid overdose, cyanide and CO poisoning, lead poisoning, and organo-phosphate poisoning, among others. For instance, according to a research article by NCBI in December 2020, there were approximately 385 million instances of unintentional pesticide poisoning worldwide, resulting in 11,000 deaths. Consequently, the market is anticipated to experience rapid growth during the forecast period.

Moreover, a series of awareness initiatives aimed at educating the public on toxin identification, coupled with government efforts to enhance knowledge of antidotes and drugs, is expected to propel the overall market growth. On the flip side, ongoing research and development endeavors are focused on improving availability, effectiveness, and safety in managing poisonings and toxic exposures, presenting lucrative opportunities for the market soon.

However, the limited availability of antidotes due to the manufacturing constraints and regulatory hurdles may impede access to the life-saving antidotes. The high costs associated with certain antidotes could create financial barriers. Additionally, storage requirements, shelf-life, and the need for knowledge and training may constrain the applications of antidotes.

Antidote Market Report Highlights

Chemical antidote held the largest share, due to minimized compilations, consistent outcomes, and precise dosing

Hospitals dominated the market, owing to increasing number of hospitalizations, batter facilities, and trained medical professionals

North America accounted for the largest share, due to rise in opioid crisis, poisoning cases, and presence of key companies involved in R&D

The key market players include Pfizer, Hikma Pharmaceuticals, Mylan, Fresenius, Zydus Lifesciences, Endo International, Baxter, & Emergent BioSolutions.

Polaris Market Research has segmented the antidote market report based on type, route of administration, distribution channel, end use, and region:

Antidote, Type Outlook (Revenue - USD Million, 2023 - 2032)

  • Chemical Antidote
  • Physical Antidote
  • Pharmacological Antidote

Antidote, Route of Administration Outlook (Revenue - USD Million, 2023 - 2032)

  • Oral
  • Topical
  • Injectable
  • Others

Antidote, Distribution Channel Outlook (Revenue - USD Million, 2023 - 2032)

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Antidote, End Use Outlook (Revenue - USD Million, 2023 - 2032)

  • Hospital
  • Homecare
  • Specialty Clinics
  • Others

Antidote, Regional Outlook (Revenue - USD Million, 2023 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Antidote Market Insights

  • 4.1. Antidote Market - Distribution Channel Snapshot
  • 4.2. Antidote Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising Incidence of Poisonings
      • 4.2.1.2. Growing Drug Abuse
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High Costs
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Antidote Market Distribution Channel Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Antidote Market, by Route of Administration

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Antidote Market, by Route of Administration, 2019-2032 (USD Million)
  • 5.3. Oral
    • 5.3.1. Global Antidote Market, by Oral, by Region, 2019-2032 (USD Million)
  • 5.4. Topical
    • 5.4.1. Global Antidote Market, by Topical, by Region, 2019-2032 (USD Million)
  • 5.5. Injectable
    • 5.5.1. Global Antidote Market, by Injectable, by Region, 2019-2032 (USD Million)
  • 5.6. Others
    • 5.6.1. Global Antidote Market, by Others, by Region, 2019-2032 (USD Million)

6. Global Antidote Market, by Type

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Antidote Market, by Type, 2019-2032 (USD Million)
  • 6.3. Chemical Antidote
    • 6.3.1. Global Antidote Market, by Chemical Antidote, by Region, 2019-2032 (USD Million)
  • 6.4. Physical Antidote
    • 6.4.1. Global Antidote Market, by Physical Antidote, by Region, 2019-2032 (USD Million)
  • 6.5. Pharmacological Antidote
    • 6.5.1. Global Antidote Market, by Pharmacological Antidote, by Region, 2019-2032 (USD Million)

7. Global Antidote Market, by Distribution Channel

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
  • 7.3. Hospital Pharmacies
    • 7.3.1. Global Antidote Market, by Hospital Pharmacies, By Region, 2019-2032 (USD Million)
  • 7.4. Retail Pharmacies
    • 7.4.1. Global Antidote Market, by Retail Pharmacies, By Region, 2019-2032 (USD Million)
  • 7.5. Online Pharmacies
    • 7.5.1. Global Antidote Market, by Online Pharmacies, By Region, 2019-2032 (USD Million)

8. Global Antidote Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Antidote Market Assessment, By Geography, 2019-2032 (USD Million)
  • 8.3. Antidote Market - North America
    • 8.3.1. North America: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
    • 8.3.2. North America: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
    • 8.3.3. North America: Antidote Market, by Type, 2019-2032 (USD Million)
    • 8.3.4. Antidote Market - U.S.
      • 8.3.4.1. U.S.: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
      • 8.3.4.2. U.S.: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.3.4.3. U.S.: Antidote Market, by Type, 2019-2032 (USD Million)
    • 8.3.5. Antidote Market - Canada
      • 8.3.5.1. Canada: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
      • 8.3.5.2. Canada.: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.3.5.3. Canada: Antidote Market, by Type, 2019-2032 (USD Million)
  • 8.4. Antidote Market - Europe
    • 8.4.1. Europe: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
    • 8.4.2. Europe.: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
    • 8.4.3. Europe: Antidote Market, by Type, 2019-2032 (USD Million)
    • 8.4.4. Antidote Market - UK
      • 8.4.4.1. UK: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
      • 8.4.4.2. UK.: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.4.4.3. UK: Antidote Market, by Type, 2019-2032 (USD Million)
    • 8.4.5. Antidote Market - France
      • 8.4.5.1. France: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
      • 8.4.5.2. France.: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.4.5.3. France: Antidote Market, by Type, 2019-2032 (USD Million)
    • 8.4.6. Antidote Market - Germany
      • 8.4.6.1. Germany: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
      • 8.4.6.2. Germany.: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.4.6.3. Germany: Antidote Market, by Type, 2019-2032 (USD Million)
    • 8.4.7. Antidote Market - Italy
      • 8.4.7.1. Italy: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
      • 8.4.7.2. Italy.: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.4.7.3. Italy: Antidote Market, by Type, 2019-2032 (USD Million)
    • 8.4.8. Antidote Market - Spain
      • 8.4.8.1. Spain: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
      • 8.4.8.2. Spain.: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.4.8.3. Spain: Antidote Market, by Type, 2019-2032 (USD Million)
    • 8.4.9. Antidote Market - Netherlands
      • 8.4.9.1. Netherlands: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
      • 8.4.9.2. Netherlands.: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.4.9.3. Netherlands: Antidote Market, by Type, 2019-2032 (USD Million)
    • 8.4.10. Antidote Market - Russia
      • 8.4.10.1. Russia: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
      • 8.4.10.2. Russia.: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.4.10.3. Russia: Antidote Market, by Type, 2019-2032 (USD Million)
  • 8.5. Antidote Market - Asia Pacific
    • 8.5.1. Asia Pacific: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
    • 8.5.2. Asia Pacific.: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
    • 8.5.3. Asia Pacific: Antidote Market, by Type, 2019-2032 (USD Million)
    • 8.5.4. Antidote Market - China
      • 8.5.4.1. China: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
      • 8.5.4.2. China.: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.5.4.3. China: Antidote Market, by Type, 2019-2032 (USD Million)
    • 8.5.5. Antidote Market - India
      • 8.5.5.1. India: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
      • 8.5.5.2. India.: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.5.5.3. India: Antidote Market, by Type, 2019-2032 (USD Million)
    • 8.5.6. Antidote Market - Malaysia
      • 8.5.6.1. Malaysia: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
      • 8.5.6.2. Malaysia.: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.5.6.3. Malaysia: Antidote Market, by Type, 2019-2032 (USD Million)
    • 8.5.7. Antidote Market - Japan
      • 8.5.7.1. Japan: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
      • 8.5.7.2. Japan.: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.5.7.3. Japan: Antidote Market, by Type, 2019-2032 (USD Million)
    • 8.5.8. Antidote Market - Indonesia
      • 8.5.8.1. Indonesia: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
      • 8.5.8.2. Indonesia.: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.5.8.3. Indonesia: Antidote Market, by Type, 2019-2032 (USD Million)
    • 8.5.9. Antidote Market - South Korea
      • 8.5.9.1. South Korea: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
      • 8.5.9.2. South Korea.: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.5.9.3. South Korea: Antidote Market, by Type, 2019-2032 (USD Million)
  • 8.6. Antidote Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
    • 8.6.2. Middle East & Africa.: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
    • 8.6.3. Middle East & Africa: Antidote Market, by Type, 2019-2032 (USD Million)
    • 8.6.4. Antidote Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
      • 8.6.4.2. Saudi Arabia.: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.6.4.3. Saudi Arabia: Antidote Market, by Type, 2019-2032 (USD Million)
    • 8.6.5. Antidote Market - UAE
      • 8.6.5.1. UAE: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
      • 8.6.5.2. UAE.: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.6.5.3. UAE: Antidote Market, by Type, 2019-2032 (USD Million)
    • 8.6.6. Antidote Market - Israel
      • 8.6.6.1. Israel: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
      • 8.6.6.2. Israel.: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.6.6.3. Israel: Antidote Market, by Type, 2019-2032 (USD Million)
    • 8.6.7. Antidote Market - South Africa
      • 8.6.7.1. South Africa: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
      • 8.6.7.2. South Africa.: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.6.7.3. South Africa: Antidote Market, by Type, 2019-2032 (USD Million)
  • 8.7. Antidote Market - Latin America
    • 8.7.1. Latin America: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
    • 8.7.2. Latin America.: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
    • 8.7.3. Latin America: Antidote Market, by Type, 2019-2032 (USD Million)
    • 8.7.4. Antidote Market - Mexico
      • 8.7.4.1. Mexico: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
      • 8.7.4.2. Mexico.: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.7.4.3. Mexico: Antidote Market, by Type, 2019-2032 (USD Million)
    • 8.7.5. Antidote Market - Brazil
      • 8.7.5.1. Brazil: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
      • 8.7.5.2. Brazil.: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.7.5.3. Brazil: Antidote Market, by Type, 2019-2032 (USD Million)
    • 8.7.6. Antidote Market - Argentina
      • 8.7.6.1. Argentina: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
      • 8.7.6.2. Argentina.: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.7.6.3. Argentina: Antidote Market, by Type, 2019-2032 (USD Million)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Pfizer Inc.
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Hikma Pharmaceuticals PLC
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Dr. Reddy's Laboratories Ltd
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Mylan N.V.
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Fresenius Kabi AG
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Zydus Lifesciences Ltd.
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Endo International plc
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Novartis AG
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Baxter International, Inc.
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Emergent BioSolutions Inc
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development